Extracorporeal membrane oxygenation shows benefit for patients with COVID-19 related severe acute respiratory distress syndrome.
1. Extracorporeal membrane oxygenation (ECMO) for COVID-19 related acute respiratory distress syndrome (ARDS) was associated with 60-day survival rates similar...